Cederberg, H. et al. (2015) ‘Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort’, Diabetologia, 58(5), pp. 1109–1117. doi:10.1007/s00125-015-3528-5. https://link.springer.com/article/10.1007/s00125-015-3528-5
Chudzik, A. et al. (2021) ‘Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain–Gut–Microbiome Axis’, Biomolecules, 11(7), p. 1000. doi:10.3390/biom11071000. https://www.mdpi.com/2218-273X/11/7/1000
Cummings, R.D. and L. Schnaar, R. (2015) ‘R-Type Lectins’, in A. Varki et al. (eds) Essentials of Glycobiology. 3rd edn. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press. Available at: http://www.ncbi.nlm.nih.gov/books/NBK453065/ (Accessed: 5 August 2022).
Davis, W. (2019) Wheat Belly. Harmony/Rodale. Kindle Edition.
Diamond, D.M. and Ravnskov, U. (2015) ‘How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease’, Expert Review of Clinical Pharmacology, 8(2), pp. 201–210. doi:10.1586/17512433.2015.1012494. https://www.tandfonline.com/doi/full/10.1586/17512433.2015.1012494
Geleijnse, J.M. et al. (2004) ‘Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study’, The Journal of Nutrition, 134(11), pp. 3100–3105. doi:10.1093/jn/134.11.3100. https://academic.oup.com/jn/article/134/11/3100/4688389
Hyman, M. (2016) Eat Fat, Get Thin: Why the Fat We Eat Is the Key to Sustained Weight Loss and Vibrant Health. Illustrated edition. Little, Brown Spark.
Kearns, C.E., Schmidt, L.A. and Glantz, S.A. (2016) ‘Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents’, JAMA Internal Medicine, 176(11), pp. 1680–1685. doi:10.1001/jamainternmed.2016.5394.
Kristensen, M.L., Christensen, P.M. and Hallas, J. (2015) ‘The effect of statins on average survival in randomised trials, an analysis of end point postponement’, BMJ Open, 5(9), p. e007118. doi:10.1136/bmjopen-2014-007118. https://bmjopen.bmj.com/content/5/9/e007118
Mandatori, D. et al. (2021) ‘The dual role of vitamin K2 in “bone-vascular crosstalk”: Opposite effects on bone loss and vascular calcification’, Nutrients, 13(4). doi:10.3390/nu13041222. https://www.mdpi.com/2072-6643/13/4/1222
Mills, C.E., Hall, W.L. and Berry, S.E.E. (2017) ‘What are interesterified fats and should we be worried about them in our diet?’, Nutrition Bulletin, 42(2), pp. 153–158. Available at: https://doi.org/10.1111/nbu.12264.
de la Monte, S.M. and Wands, J.R. (2008) ‘Alzheimer’s Disease Is Type 3 Diabetes–Evidence Reviewed’, Journal of diabetes science and technology (Online), 2(6), pp. 1101–1113. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769828/ (Accessed: 28 April 2022).
Moro, T. et al. (2020) ‘Time-restricted eating effects on performance, immune function, and body composition in elite cyclists: a randomized controlled trial’, Journal of the International Society of Sports Nutrition, 17(1), p. 65. doi:10.1186/s12970-020-00396-z. https://www.tandfonline.com/doi/full/10.1186/s12970-020-00396-z
Norwitz, N.G. et al. (2022) ‘Elevated LDL Cholesterol with a Carbohydrate-Restricted Diet: Evidence for a “Lean Mass Hyper-Responder” Phenotype’, Current Developments in Nutrition, 6(1), p. nzab144. doi:10.1093/cdn/nzab144. https://academic.oup.com/cdn/article/6/1/nzab144/6446805
Padala, K.P. et al. (2012) ‘The Effect of HMG-CoA Reductase Inhibitors on Cognition in Patients With Alzheimer’s Dementia: A Prospective Withdrawal and Rechallenge Pilot Study’, The American Journal of Geriatric Pharmacotherapy, 10(5), pp. 296–302. doi:10.1016/j.amjopharm.2012.08.002. https://www.sciencedirect.com/science/article/abs/pii/S1543594612001092
Ravnskov, U. et al. (2016) ‘Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review’, BMJ Open, 6(6), p. e010401. doi:10.1136/bmjopen-2015-010401. https://bmjopen.bmj.com/content/6/6/e010401
Ridker, P.M. et al. (2008) ‘Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein’, New England Journal of Medicine, 359(21), pp. 2195–2207. doi:10.1056/NEJMoa0807646. https://www.nejm.org/doi/full/10.1056/NEJMoa0807646
Rong, Y. et al. (2013) ‘Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies’, BMJ, 346(jan07 2), pp. e8539–e8539. doi:10.1136/bmj.e8539. https://www.bmj.com/content/346/bmj.e8539
Sechtem, U. et al. (no date) ‘2013 ESC guidelines on the management of stable coronary artery disease—addenda’, p. 32.
Sever, P.S. et al. (2003) ‘Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial’, The Lancet, 361(9364), pp. 1149–1158. doi:10.1016/S0140-6736(03)12948-0. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(03)12948-0/fulltext
Simopoulos, A.P. (2006) ‘Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases’, Biomedicine & Pharmacotherapy, 60(9), pp. 502–507. Available at: https://doi.org/10.1016/j.biopha.2006.07.080.
Skeaff, C.M. and Miller, J. (2009) ‘Dietary Fat and Coronary Heart Disease: Summary of Evidence from Prospective Cohort and Randomised Controlled Trials’, Annals of Nutrition & Metabolism, 55(1/3), pp. 173–201. Available at: https://www.jstor.org/stable/48514098 (Accessed: 18 April 2022).
Stamler, J., Wentworth, D. and Neaton, J.D. (1986) ‘Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?: Findings in 356 222 Primary Screenees of the Multiple Risk Factor Intervention Trial (MRFIT)’, JAMA, 256(20), pp. 2823–2828. doi:10.1001/jama.1986.03380200061022. https://jamanetwork.com/journals/jama/article-abstract/363231
van Rooijen, M.A. and Mensink, R.P. (2020) ‘Palmitic Acid Versus Stearic Acid: Effects of Interesterification and Intakes on Cardiometabolic Risk Markers—A Systematic Review’, Nutrients, 12(3), p. 615. Available at: https://doi.org/10.3390/nu12030615.